Optimal number of neoadjuvant chemotherapy cycles prior to interval debulking surgery in advanced epithelial ovarian cancer: a systematic review and meta-analysis of progression-free survival and overall survival

OBJECTIVE: Neoadjuvant chemotherapy (NACT) represents a treatment option in patients with advanced epithelial ovarian cancer (AEOC) who are not good candidates for primary debulking surgery. Usually, 3 cycles of chemotherapy before surgery have been considered the best option for patient survival, a...

Descripción completa

Detalles Bibliográficos
Autores principales: Coada, Camelia Alexandra, Dondi, Giulia, Ravegnini, Gloria, Di Costanzo, Stella, Tesei, Marco, Fiuzzi, Enrico, Di Stanislao, Marco, Giunchi, Susanna, Zamagni, Claudio, Bovicelli, Alessandro, Hrelia, Patrizia, Angelini, Sabrina, De Iaco, Pierandrea, Perrone, Anna Myriam
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Asian Society of Gynecologic Oncology; Korean Society of Gynecologic Oncology; Japan Society of Gynecologic Oncology 2023
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10627748/
https://www.ncbi.nlm.nih.gov/pubmed/37743060
http://dx.doi.org/10.3802/jgo.2023.34.e82

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10627748/
https://www.ncbi.nlm.nih.gov/pubmed/37743060
http://dx.doi.org/10.3802/jgo.2023.34.e82

Ejemplares similares